Technical Analysis for SKYE - Skye Bioscience, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 12.93 | -0.54% | -0.07 |
SKYE closed down 0.54 percent on Tuesday, April 30, 2024, on 71 percent of normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Hammer Candlestick | Bullish | 0.00% | |
Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
20 DMA Resistance | Bearish | -0.54% | |
Narrow Range Bar | Range Contraction | -0.54% | |
Wide Bands | Range Expansion | -0.54% | |
Gapped Up | Strength | -0.54% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -0.54% |
Alert | Time |
---|---|
50 DMA Support | about 9 hours ago |
Down 3% | about 9 hours ago |
Fell Below Previous Day's Low | about 9 hours ago |
Down 2 % | about 9 hours ago |
Down 1% | about 9 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/05/2024
Skye Bioscience, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. It focuses on the treatment of a spectrum of diseases, as well as utilizing bioengineering in drug design. Its product pipeline includes SBI-100 and SBI-200. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Drug Design
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Drug Design
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.4099 |
52 Week Low | 0.0074 |
Average Volume | 52,410 |
200-Day Moving Average | 4.42 |
50-Day Moving Average | 12.75 |
20-Day Moving Average | 13.26 |
10-Day Moving Average | 14.39 |
Average True Range | 1.57 |
RSI (14) | 43.18 |
ADX | 17.58 |
+DI | 30.00 |
-DI | 27.39 |
Chandelier Exit (Long, 3 ATRs) | 12.95 |
Chandelier Exit (Short, 3 ATRs) | 12.05 |
Upper Bollinger Bands | 17.85 |
Lower Bollinger Band | 8.68 |
Percent B (%b) | 0.46 |
BandWidth | 69.15 |
MACD Line | 0.30 |
MACD Signal Line | 0.57 |
MACD Histogram | -0.2747 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 13.67 | ||||
Resistance 3 (R3) | 13.61 | 13.31 | 13.54 | ||
Resistance 2 (R2) | 13.31 | 13.12 | 13.34 | 13.50 | |
Resistance 1 (R1) | 13.12 | 13.01 | 12.97 | 13.18 | 13.46 |
Pivot Point | 12.82 | 12.82 | 12.75 | 12.85 | 12.82 |
Support 1 (S1) | 12.63 | 12.63 | 12.48 | 12.69 | 12.40 |
Support 2 (S2) | 12.33 | 12.52 | 12.36 | 12.36 | |
Support 3 (S3) | 12.14 | 12.33 | 12.32 | ||
Support 4 (S4) | 12.20 |